首页> 外文OA文献 >Microsurgical resection of fronto-temporo-insular gliomas in the non-dominant hemisphere, under general anesthesia using adjunct intraoperative MRI and no cortical and subcortical mapping: a series of 20 consecutive patients
【2h】

Microsurgical resection of fronto-temporo-insular gliomas in the non-dominant hemisphere, under general anesthesia using adjunct intraoperative MRI and no cortical and subcortical mapping: a series of 20 consecutive patients

机译:在非显性半球的前颞神经胶质瘤的显微外科切除,在一般麻醉下使用辅助术中MRI和没有皮质和皮质测绘:一系列连续20名患者

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Abstract Fronto-temporo-insular (FTI) gliomas continue to represent a surgical challenge despite numerous technical advances. Some authors advocate for surgery in awake condition even for non-dominant hemisphere FTI, due to risk of sociocognitive impairment. Here, we report outcomes in a series of patients operated using intraoperative magnetic resonance imaging (IoMRI) guided surgery under general anesthesia, using no cortical or subcortical mapping. We evaluated the extent of resection, functional and neuropsychological outcomes after IoMRI guided surgery under general anesthesia of FTI gliomas located in the non-dominant hemisphere. Twenty patients underwent FTI glioma resection using IoMRI in asleep condition. Seventeen tumors were de novo, three were recurrences. Tumor WHO grades were II:12, III:4, IV:4. Patients were evaluated before and after microsurgical resection, clinically, neuropsychologically (i.e., social cognition) and by volumetric MR measures (T1G+ for enhancing tumors, FLAIR for non-enhancing). Fourteen (70%) patients benefited from a second IoMRI. The median age was 33.5 years (range 24–56). Seizure was the inaugural symptom in 71% of patients. The median preoperative volume was 64.5 cm3 (min 9.9, max 211). Fourteen (70%) patients underwent two IoMRI. The final median EOR was 92% (range 69–100). The median postoperative residual tumor volume (RTV) was 4.3 cm3 (range 0–38.2). A vast majority of residual tumors were located in the posterior part of the insula. Early postoperative clinical events (during hospital stay) were three transient left hemiparesis (which lasted less than 48 h) and one prolonged left brachio-facial hemiparesis. Sixty percent of patients were free of any symptom at discharge. The median Karnofsky Performance Score was of 90 both at discharge and at 3 months. No significant neuropsychological impairment was reported, excepting empathy distinction in less than 40% of patients. After surgery, 45% of patients could go back to work. In our experience and using IoMRI as an adjunct, microsurgical resection of non-dominant FTI gliomas under general anesthesia is safe. Final median EOR was 92%, with a vast majority of residual tumors located in the posterior insular part. Patients experienced minor neurological and neuropsychological morbidity. Moreover, neuropsychological evaluation reported a high preservation of sociocognitive abilities. Solely empathy seemed to be impaired in some patients.
机译:摘要虽然众多技术进步,但摘要普遍存在的前端(FTI)Gliomas继续代表手术挑战。由于社会认知障碍的风险,一些作者们甚至是由于非主导的半球FTI的清醒条件的手术。在这里,我们在一般麻醉下使用术中磁共振成像(Iomri)引导手术在一系列患者中报告了一系列患者的结果,使用没有皮质或皮质映射。在IOMRI引导手术下在非显性半球的FTI Gliomas全身麻醉下,我们评估了Iomri引导手术后的切除术,功能和神经心理学结果的程度。二十名患者在睡眠条件下使用Iomri的FTI胶质瘤切除切除。十七种肿瘤是德诺维,三个是复发。患者的肿瘤是II:12,ii:4,IV:4。在显微外切除之前和之后评估患者,临床,神经心理学上(即社会认知)和体积MR措施(T1G +用于增强肿瘤,Frair的T1G +,用于非增强)。十四(70%)患者受益于第二个Iomri。中位年龄为33.5岁(范围为24-56)。癫痫发作是71%的患者的就职症状。中位术前体积为64.5cm 3(最小9.9,最多211)。十四(70%)患者接受过两名Iomri。最终中位EOR为92%(范围69-100)。中位术后残留肿瘤体积(RTV)为4.3cm 3(范围0-38.2)。绝大多数残留的肿瘤位于insula的后部。术后早期临床事件(在住院期间)是三次短暂的左侧血清(持续低于48小时),一个延长左右的左右的血管面部内血清。六十百分之六十名患者在排出时没有任何症状。中位数karnofsky性能评分在出院时均为90分,3个月。报告了没有显着的神经心理学障碍,除了不到40%的患者的移情区别。手术后,45%的患者可以回去工作。在我们的经验和Iomri作为辅助,在全身麻醉下的非显性FTI胶质瘤的显微外科切除是安全的。最终中位EOR为92%,占绝大多数残留肿瘤位于后部占状部分。患者经历了微小的神经和神经心理发病率。此外,神经心理学评估报告据报道高度保存社会学认知能力。完全同情似乎在某些患者中受损。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号